MYX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Mayne Pharma Group Insider Trading History Chart

This chart shows the insider buying and selling history at Mayne Pharma Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mayne Pharma Group Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/12/2020 01:00 AM ET

This chart shows the closing price history over time for MYX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Bear Market Expert Reveals His #1 Stock for November 2023 
"I went from the brink of bankruptcy to wealthy – thanks to one type of stock". Get his top pick here.
>>>
pixel

Mayne Pharma Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/30/2022Scott RichardsInsiderTransfer5,585,369A$0.28A$1,535,976.48
8/1/2022Scott RichardsInsiderCancelled6,608,851A$0.35A$2,313,097.85
9/1/2021Frank CondellaInsiderBuy412,121A$0.33A$136,824.17
12/4/2020Scott RichardsInsiderIssued8,643,782A$0.36A$3,068,542.61
8/31/2020Scott RichardsInsiderCancelled2,553,496A$0.34A$855,421.16
3/11/2020Bruce MathiesonInsiderBuy3,112,726A$0.32A$983,621.42
3/3/2020Bruce MathiesonInsiderBuy3,687,274A$0.32A$1,168,865.86
12/9/2019Scott RichardsInsiderIssued2,555,805A$0.43A$1,098,996.15
See Full Table
Bear Market Expert Reveals His #1 Stock for November 2023 
"I went from the brink of bankruptcy to wealthy – thanks to one type of stock". Get his top pick here.
>>>
pixel

SEC Filings (Institutional Ownership Changes) for Mayne Pharma Group (ASX:MYX)

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Read More on Mayne Pharma Group

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

5,467,533 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

13.82%

Beta

N/A

Who are the company insiders with the largest holdings of Mayne Pharma Group?

Mayne Pharma Group's top insider investors include:
  1. Frank Condella (Insider)
  2. Scott Richards (Insider)
Learn More about top insider investors at Mayne Pharma Group.